Generation of a New Humanized Pompe Disease Model for Improved Robust // Pre-Clinical Evaluation of new Pompe Therapeutics
Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).Autores: Ortiz-Bueno M, Ramos-Hernández I, Algeciras-Jiménez L, Kalter N, Rodríguez-Madoz JR, Bonafont J, Nair RR, Feeney O, Torella L, Montoliu L, Patsali P, Mussolino C, Luo Y, Xhetani M, Cavazza A, Hendel A, Benabdellah K, Lederer CW, Molina-Estévez FJ11/2025 - Frontiers in genome editing
Short communication: Dynamic chemical labelling allows the measurement of the paracetamol toxicity biomarker microRNA-122 in hospital clinical laboratories.Autores: Alzeer S, Marin-Romero A, López-Longarela B, Guardia-Monteagudo JJ, Lopez-Delgado FJ, Pernagallo S, Diaz-Mochon JJ, Tabraue-Chavez M, Scullion K, Dear JW11/2025 - British journal of clinical pharmacology
Melatonin Overcomes Cancer Multidrug Resistance by Downregulating ABCB1 Expression and Modulating Mitochondrial Function.Autores: López-Rodríguez A, Martinez-Ruiz L, Morales-Gallel R, Florido J, Bermejo-Casares F, Garcia-Verdugo JM, Estebané MM, Carriel V, Maldonado-Pérez N, González-García P, Ahmadpour ST, Ramírez-Casas Y, Martín F, Dumas JF, Vandier C, Yang Y, Acuña-Castroviejo D, Escames G11/2025 - Journal of pineal research
